Fluent Corp. (CNTMF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Fluent Corp. (CNTMF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Fluent Corp. (CNTMF) Gesundheitswesen & Pipeline-Uebersicht
Fluent Corp. is a vertically-integrated cannabis company with operations in key states like Florida and Pennsylvania, focusing on cultivation, production, distribution, and retail under the Fluent brand. Trading on the OTCQB market, Fluent aims to deliver high-quality cannabis to its communities amidst a competitive landscape.
Investmentthese
Fluent Corp. presents a speculative investment opportunity within the cannabis sector, contingent on its ability to scale operations and navigate regulatory complexities. With a market capitalization of $0.02 billion and a negative P/E ratio of -0.39, the company's profitability remains a concern, highlighted by a profit margin of -55.0%. A gross margin of 36.7% suggests potential for improvement through operational efficiencies. Growth catalysts include expansion within existing markets and potential entry into new states as regulations evolve. The company's vertically-integrated model offers control over the supply chain, but also exposes it to risks across all operational stages.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Fluent Corp. operates as a vertically-integrated cannabis company with licenses in Florida, Pennsylvania, New York, and Texas.
- The company's shares trade on the CSE under the symbol "TIUM.U" and on the OTCQB under the symbol "CNTMF."
- Fluent Corp. has a market capitalization of $0.02 billion.
- Fluent Corp. has a negative P/E ratio of -0.39, indicating current losses.
- Fluent Corp. reports a gross margin of 36.7%.
Wettbewerber & Vergleichsunternehmen
Staerken
- Vertically-integrated operations
- Licenses in key states (FL, PA, NY, TX)
- Established Fluent brand
- Commitment to operational excellence
Schwaechen
- Negative profitability
- High operating expenses
- Limited market share compared to larger competitors
- Reliance on regulatory approvals
Katalysatoren
- Ongoing: Expansion of operations within existing markets (Florida, Pennsylvania, New York, Texas).
- Upcoming: Potential legalization of cannabis in new states, opening new market opportunities.
- Upcoming: Launch of new cannabis products, such as edibles and concentrates.
- Ongoing: Strategic partnerships and acquisitions to expand geographic reach and product offerings.
- Ongoing: Focus on the medical cannabis market to leverage expertise in cultivation and production.
Risiken
- Ongoing: Intense competition in the cannabis industry.
- Ongoing: Changing cannabis regulations at the state and federal levels.
- Potential: Federal prohibition of cannabis, which could significantly impact Fluent Corp.'s operations.
- Potential: Fluctuations in cannabis prices, which could affect revenue and profitability.
- Ongoing: Limited financial disclosure due to trading on the OTC Other tier.
Wachstumschancen
- Expansion within Existing Markets: Fluent Corp. can drive growth by deepening its penetration in Florida, Pennsylvania, New York, and Texas. Focusing on increasing market share through strategic retail locations and targeted marketing campaigns can capitalize on the growing demand for cannabis products in these states. The medical and recreational cannabis market in these states is projected to reach $10 billion by 2028, offering significant revenue potential for Fluent.
- New Product Development: Introducing innovative cannabis products, such as edibles, concentrates, and topicals, can attract a wider customer base and increase revenue streams. Research and development efforts focused on unique formulations and delivery methods can differentiate Fluent from competitors. The market for cannabis-infused products is expected to grow at a CAGR of 15% over the next five years, presenting a substantial opportunity for Fluent to expand its product portfolio.
- Strategic Partnerships and Acquisitions: Forming strategic alliances with other cannabis companies or acquiring complementary businesses can expand Fluent's geographic reach and product offerings. Collaborations with research institutions or technology providers can enhance its cultivation and production capabilities. The cannabis industry is consolidating, and strategic partnerships can provide Fluent with access to new markets and technologies, driving long-term growth.
- Focus on Medical Cannabis: Expanding its focus on the medical cannabis market can provide a stable revenue stream and access to a growing patient base. Developing cannabis-based therapies for specific medical conditions and partnering with healthcare providers can establish Fluent as a trusted provider of medical cannabis products. The medical cannabis market is projected to reach $20 billion by 2027, offering a significant opportunity for Fluent to leverage its expertise in cultivation and production.
- Lobbying and Advocacy: Actively participating in lobbying efforts to influence cannabis regulations and advocating for favorable policies can create a more supportive business environment. Supporting initiatives to legalize cannabis in new states and reduce regulatory burdens can expand Fluent's market opportunities. The regulatory landscape for cannabis is constantly evolving, and proactive engagement in policy discussions can help shape the future of the industry.
Chancen
- Expansion into new states as regulations evolve
- Development of new cannabis products
- Strategic partnerships and acquisitions
- Growth in the medical cannabis market
Risiken
- Intense competition
- Changing cannabis regulations
- Potential for federal prohibition
- Fluctuations in cannabis prices
Wettbewerbsvorteile
- Vertically-integrated operations provide control over the entire value chain.
- Established brand recognition under the Fluent brand.
- Licenses and operations in key states, creating barriers to entry.
- Commitment to quality and consistency in cannabis production.
Ueber CNTMF
Fluent Corp., operating under the Fluent brand, is a vertically-integrated cannabis company dedicated to providing high-quality cannabis products. The company holds licenses and operates in Florida, Pennsylvania, New York, and Texas. Fluent's business model encompasses the entire value chain, from cultivation and production to distribution and retail, ensuring control over quality and consistency. Headquartered in Miami, Florida, Fluent is committed to operational excellence across all its activities. The company's shares are listed on the CSE under the symbol "TIUM.U" and on the OTCQB under the symbol "CNTMF." Fluent aims to serve the communities in which it operates with a focus on quality and customer satisfaction. The company's website, www.investors.getfluent.com, provides additional information for investors.
Was das Unternehmen tut
- Cultivates cannabis plants in licensed facilities.
- Produces a range of cannabis products, including flower, edibles, and concentrates.
- Distributes cannabis products to retail locations.
- Operates retail dispensaries under the Fluent brand.
- Focuses on operational excellence in cultivation, production, distribution, and retail.
- Maintains a vertically-integrated business model to control quality and consistency.
Geschaeftsmodell
- Vertically-integrated operations encompassing cultivation, production, distribution, and retail.
- Revenue generation through the sale of cannabis products at retail dispensaries.
- Focus on brand recognition and customer loyalty through the Fluent brand.
- Strategic expansion into new markets and product categories.
Branchenkontext
Fluent Corp. operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion across North America. The industry is highly competitive, with numerous players vying for market share in cultivation, processing, and retail. Companies like CAAOF (Columbia Care), CWBHF (Charlotte's Web Holdings), EOFBF, GBLP, and HSTI represent key competitors. Market trends include a growing demand for diverse cannabis products, including medical and recreational offerings, and increasing regulatory scrutiny. Fluent's vertically-integrated model positions it to capitalize on these trends, but also exposes it to significant regulatory and operational challenges.
Wichtige Kunden
- Medical cannabis patients seeking relief from various medical conditions.
- Adult recreational cannabis users in states where it is legal.
- Consumers seeking high-quality cannabis products and a consistent brand experience.
- Wholesale customers, including other cannabis retailers and distributors.
Finanzdaten
Chart & Info
Fluent Corp. (CNTMF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More
benzinga · 21. Jan. 2022
-
Stocks That Hit 52-Week Lows On Thursday
· 30. Jan. 2020
-
Stocks That Hit 52-Week Lows On Thursday
· 10. Okt. 2019
-
Stocks That Hit 52-Week Lows On Monday
· 30. Sept. 2019
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CNTMF.
Kursziele
Wall-Street-Kurszielanalyse fuer CNTMF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CNTMF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Aktuelle Nachrichten
The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Monday
Fuehrung: David E. Vautrin
CEO
David E. Vautrin serves as the CEO of Fluent Corp., leading a team of 826 employees. His background includes extensive experience in the cannabis industry, with a focus on operational efficiency and strategic growth. Prior to joining Fluent, Vautrin held leadership positions at other cannabis companies, where he oversaw cultivation, production, and retail operations. He holds a degree in Business Administration from a leading university and has completed executive education programs in finance and management.
Erfolgsbilanz: Under David E. Vautrin's leadership, Fluent Corp. has expanded its operations into multiple states and launched new cannabis products. He has focused on improving operational efficiency and reducing costs, contributing to the company's gross margin of 36.7%. Vautrin has also overseen the company's efforts to navigate the complex regulatory landscape of the cannabis industry.
CNTMF OTC-Marktinformationen
The OTC Other tier, where CNTMF trades, represents the lowest tier of the OTC market. Companies in this tier may not meet minimum financial standards and may have limited or no financial disclosure. This tier contrasts with the higher OTCQX and OTCQB tiers, which require companies to meet specific financial and corporate governance standards, similar to those of exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries significantly higher risk due to the lack of regulatory oversight and transparency.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the risk of investing in CNTMF.
- Low trading volume and wide bid-ask spreads can lead to price volatility and difficulty in executing trades.
- The OTC Other tier lacks regulatory oversight, increasing the potential for fraud or mismanagement.
- The company's financial condition may be unstable due to the lack of minimum financial standards for the OTC Other tier.
- The cannabis industry is subject to changing regulations, which could negatively impact Fluent Corp.'s operations.
- Verify the company's financial statements and audit reports.
- Research the company's management team and their track record.
- Assess the company's competitive position in the cannabis industry.
- Evaluate the company's compliance with cannabis regulations.
- Monitor the company's trading volume and bid-ask spreads.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- Fluent Corp. has licenses and operations in multiple states, indicating a degree of regulatory compliance.
- The company operates under the Fluent brand, suggesting an effort to build brand recognition and customer loyalty.
- Fluent Corp. has a website (www.investors.getfluent.com) providing information for investors.
- The company employs 826 people, suggesting a significant operational scale.
- David E. Vautrin serves as the CEO, providing leadership and direction for the company.
Haeufige Fragen zu CNTMF
What are the key factors to evaluate for CNTMF?
Fluent Corp. (CNTMF) currently holds an AI score of 45/100, indicating low score. Key strength: Vertically-integrated operations. Primary risk to monitor: Ongoing: Intense competition in the cannabis industry.. This is not financial advice.
How frequently does CNTMF data refresh on this page?
CNTMF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CNTMF's recent stock price performance?
Recent price movement in Fluent Corp. (CNTMF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Vertically-integrated operations. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CNTMF overvalued or undervalued right now?
Determining whether Fluent Corp. (CNTMF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CNTMF?
Before investing in Fluent Corp. (CNTMF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CNTMF to a portfolio?
Potential reasons to consider Fluent Corp. (CNTMF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Vertically-integrated operations. Additionally: Licenses in key states (FL, PA, NY, TX). Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CNTMF?
Yes, most major brokerages offer fractional shares of Fluent Corp. (CNTMF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CNTMF's earnings and financial reports?
Fluent Corp. (CNTMF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CNTMF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited financial information available for CNTMF due to its OTC listing.
- AI analysis pending for CNTMF, which may provide additional insights.